ReGelTec, Inc.
ReGelTec, Inc., based in Baltimore, MD, is a clinical stage medical device company focused on developing innovative interventional spinal implants to address chronic low back pain resulting from degenerative disc disease. Their proprietary technology, HYDRAFIL, features an injectable hydrogel that aims to provide a minimally invasive treatment option with a short recovery time and promising early clinical results.
The company recently received recognition for its research, with Dr. Douglas Beall winning the Top Abstract Award at the American Society of Pain and Neuroscience annual meeting for presenting three-year follow-up data on patients treated with their HYDRAFIL System. In addition, ReGelTec has secured FDA approval for an Investigational Device Exemption (IDE) to conduct pivotal studies to support the premarket approval of HYDRAFIL.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.